Background/Objectives: Reduced food intake, appetite loss and alteration of ghrelin and PYY 3À36 secretion have been suggested to have a function in the loss of body weight commonly observed after gastrectomy. The objective of this study was to investigate the circulating concentrations of ghrelin and PYY 3À36 and their relationships with food intake, appetite and resting energy expenditure (REE) after gastrectomy plus vagotomy. Subjects/Methods: Seven patients with total gastrectomy (TG), 14 with partial gastrectomy (PG) and 10 healthy controls were studied. Habitual food intake and REE was assessed; fasting and postprandial plasma total ghrelin, PYY 3À36 concentrations and appetite ratings were determined after ingestion of a liquid test meal. Results: Differently from PG and controls, fasting ghrelin correlated with REE, and a higher energy intake was observed in the TG group. Fasting plasma ghrelin concentrations were lower in TG compared with controls, and no ghrelin response to the meal was observed in either PG or TG. Fasting plasma PYY 3À36 concentrations were not different among the groups. There was an early and exaggerated postprandial rise in PYY 3À36 levels in both PG and TG groups, but not in controls. No effect of ghrelin or PYY 3À36 concentrations was observed on hunger, prospective consumption or fullness ratings. Conclusions: Total ghrelin and PYY 3À36 do not seem to be involved with appetite or energy intake regulation after gastrectomy plus vagotomy. Ghrelin secreted by sources other than stomach is likely to have a function in the long-term regulation of body weight after TG.
Introduction
Loss of body weight is a common sequela of gastrectomy; however, there has been no consensual explanation for the impact of gastrectomy on nutritional status (Miyoshi et al., 2001; Katai et al., 2003) . Complex mechanisms seem to be involved, including abnormal transit and diarrhea (Takase et al., 2003) , dumping syndrome (Schölmerich, 2004) , reduced food intake because of early satiety and loss of appetite (Liedman et al., 2001; Bergh et al., 2003) , and alteration of endocrine status, such as reduced ghrelin release (Date et al., 2000; Hosoda et al., 2006) or increased satiety mediators such as cholecystokinin (Bergh et al., 2003) , PYY 3À36 (Stratis et al., 2006; Borg et al., 2007) or glucagon-like peptide-1 (Borg et al., 2007) .
Ghrelin increases appetite and have a function in the regulation of energy balance (Cummings et al., 2001; Borg et al., 2007) . The major source of ghrelin is the gastric fundus; plasma ghrelin concentrations are reduced by at least 50% after both total gastrectomy (TG) and the removal of the fundus (Pekic et al., 2006) . PYY 3À36 is a hormone produced by the L cells of the distal gastrointestinal tract (Batterham et al., 2003) . Intravenous infusions of PYY in humans have been shown to decrease subsequent food intake (Degen et al., 2005) . Both a continued suppression of plasma ghrelin concentrations and an early PYY response to nutrients have been suggested to be involved in body weight loss and maintenance after Roux-en-Y gastric bypass for the treatment of obesity (Chan et al., 2006) .
Vagal afferent pathways have been reported to exert a crucial function in mediating ghrelin and PYY 3À36 effects on appetite (Abbott et al., 2005; Pekic et al., 2006) . Vagotomy seems to abolish the ghrelin's orexigenic effect in rats and in humans (Le Roux et al., 2005) , as well as the circulating ghrelin suppression after the oral glucose administration in gastrectomized patients (Pekic et al., 2006) . In addition, resection of the vagus nerve prevented the inhibition of food intake promoted by PYY 3À36 administration in rodents (Koda et al., 2005) . Therefore, impairment in either ghrelin or PYY 3À36 signaling to the central nervous system through the vagus nerve might contribute to the regulation of food intake in gastrectomized and vagotomized patients.
To date, the association between appetite sensations and changes in plasma ghrelin and PYY 3À36 in patients submitted to gastrectomy for either cancer or ulcer has been poorly investigated. We have recently provided evidence that patients with partial gastrectomy (PG) or TG and vagotomy have high resting energy expenditure (REE), a nearly normal postprandial response of hunger and prospective consumption sensations, as well as an early and exacerbated postprandial fullness (Kamiji et al., 2009) . In this study, we investigated the changes in circulating ghrelin and PYY 3À36 and appetite sensations after a test meal in gastrectomized patients. We also assessed whether basal ghrelin levels correlate with REE, appetite or daily energy intake in these patients.
Patients and methods
Three groups of adult subjects were included in the study: group 1, 10 healthy controls (five males), median age: 33 years (range 24-60 years), with median body mass index (BMI) of 24.7 kg/m 2 (range 20. ). PG consisted of resection of the gastric antrum plus a variable extension of gastric body. The reasons for PG were gastric ulcer (n ¼ 4), duodenal ulcer (n ¼ 4) or gastric cancer (n ¼ 6). After antrum resection and selective vagotomy, Billroth I (n ¼ 3) Billroth II (n ¼ 8) or Roux-en-Y (n ¼ 3) was performed for transit reconstruction. The reason for TG was adenocarcinoma of the stomach and Roux-en-Y reconstruction was performed in all subjects. The study was approved by the local Ethics committee, and informed consent was obtained from all the subjects. The median time elapsed between surgery and this study was 6 years (1.9-10 years) for PG patients and 3.5 years (1.0-8.8 years) for TG patients. All subjects had their body weight stable, defined as weight change of o5% over the 3-month period preceding the study. All gastrectomized subjects were free from recurrent disease and had no history of other gastrointestinal surgery. Exclusion criteria included history of diabetes mellitus, thyroid disease, tobacco use, consumption of more than two alcoholic drinks per day or practice of aerobic exercise for 430 min three times per week.
Food intake was assessed by a 24-h food recall and a 3-day dietary record including 2 weekdays and 1 weekend day. Mean daily values of energy, carbohydrate, protein and fat intake and the number of meals during 4 days of each subject were calculated by using the 'Diet Pro' software (version 4.0, Agromidia, Vicosa, Brazil).
Each subject was studied on 2 separate days. On the first day, subjects arrived at the laboratory by automobile in the morning after an overnight fast (12 h). Indirect calorimetry (Vmax 29, SensorMedics Corporation, Yorba Linda, CA, USA) measurements were made with subjects resting supine in comfortable thermoneutral conditions. The CO 2 and O 2 analyzers were calibrated with standard calibration gases (16% O 2 and 4% CO 2 , and 26% O 2 and 0% CO 2 ) before each test. Each subject rested in supine position for 30 min before testing. After this period, a canopy was placed over the subject's head, and the calorimetric data collection was started. Oxygen consumption and CO 2 production were measured every minute for 30 min. REE was calculated according to Weir's equation (Weir, 1949) and expressed per 24 h (Da Rocha et al., 2006) . Measured REE values were compared with the REE calculated with Harris-Benedict predictive equation, using current body weight.
On the second occasion, subjects arrived at the laboratory after an overnight fast. Subjects consumed a chocolateflavored standardized liquid test meal consisting of 270 ml of water blended with 50 g of soy milk powder and 25 g of chocolate powder (360 kcal, 51% carbohydrate, 34% fat, 15% protein) within a 3-min period. Venous blood sample was drawn before (baseline, t ¼ 0), right after meal ingestion (t ¼ 1 min) and at 30-min intervals up to 210 min. At each time, subjects also completed a validated visual analogue scale questionnaire (Flint et al., 2000) on their feelings of hunger: 'How hungry do you feel?' (I am not hungry at all-I have never been hungrier); fullness: 'How satisfied do you feel?' (I am completely empty-I feel totally full) and prospective consumption: 'How much do you think you can eat?' (Nothing at all-a lot). Subjects were instructed to place a vertical mark at any point on each 10 cm scale corresponding to their feelings; appetite ratings were determined by measuring the distance from the left side of the line to the mark.
Hormone assays
Blood samples were drawn into chilled tubes containing Na 2 EDTA (1 mg/ml). Plasma was immediately separated by centrifugation at 4 1C and stored at À70 1C until assayed.
Because of the number of samples, measurements for each hormone were performed in different assays with the inclusion of controls to determine the interassay variability. Plasma ghrelin concentrations were measured by a commercially available RIA kit (LINCO Research Inc., St Charles, MO, USA), using 125 I-labeled bioactive ghrelin as a tracer molecule and a polyclonal rabbit antibody against full-length octanoylated human ghrelin. The lower limit of detection for this assay was 96 pg/ml; variation coefficients were 6.3% within assays and 8% between assays. Plasma PYY 3À36 concentrations were measured by a commercially available RIA kit (LINCO Research Inc.) using 125 I-labeled bioactive PYY as a tracer molecule and a polyclonal guinea pig antibody against human PYY 3À36 . The lower limit of detection for this assay was 21 pg/ml; variation coefficients were 5.9% within assays and 12.2% between assays. 'Change-from-baseline' in hormone concentrations was also calculated by subtracting baseline data from the values at each time point after meal ingestion.
Statistical analyses
Associations between hormone concentrations and appetite scores were assessed by using a linear mixed effect regression model (Schall, 1991) . In this model, hormone concentrations or appetite scores were used as random effects and the variables 'time', 'study group' (control, PG or TG), 'sex' and 'age' as fixed effects. The differences between groups regarding measured REE were analyzed using a two-way analysis of variance, with 'age' and 'study group' as independent variables. All analyses were performed using SAS. A P-valueo0.05 was considered to be statistically significant.
Results
The mean daily energy intake and the number of meals were higher in the TG group compared with the control and PG groups ( Table 1 ). The energy intake in relation to measured REE (%) was higher (Po0.05) in the TG group. The macronutrients intake was similar in the three groups.
A negative correlation between fasting ghrelin and measured REE (r ¼ À0.87, Po0.05), expressed in kilocalories per body weight (kg) per day, was found in the TG group but not in the control (r ¼ À0.4, P ¼ 0.20) or PG groups (r ¼ 0.09, P ¼ 0.74). No significant correlations between fasting ghrelin or PYY 3À36 and BMI or habitual energy intake were found in the TG, the PG or the control group.
Plasma ghrelin and PYY 3À36
There was no significant difference between male and female participants for baseline or the mean ghrelin concentrations throughout the study; no effect of age was found on these values.
Fasting plasma ghrelin was lower (Po0.01) in the TG group compared with controls, but not significantly different from the PG group. Mean ghrelin concentrations throughout the study (t0-t210 min) were significantly lower in both PG and TG groups compared with controls (Table 1) . In controls, ghrelin concentrations decreased significantly (Po0.01) at 60 min: (median 787; range 394-1695 pg/ml) and remained lower (Po0.05) than baseline at 90 min (median 695; range 330-1700 pg/ml), with a progressive increase to basal values subsequently (within-groups comparison, mixed linear model). Conversely, no plasma ghrelin response to the test meal was observed in PG or TG group (Figure 1) .
Neither fasting plasma PYY 3À36 concentrations nor the mean PYY 3À36 concentrations throughout the study were different among the groups (Table 1) . In response to the test meal, there was an early and exaggerated rise in PYY 3À36 levels in both PG and TG groups, but not in controls (Figure 1 ). In the control group, no PYY significant response was seen, even though individual small increases occurred at different times after the test meal. The peak of PYY 3À36 concentration occurred at 30 min in both PG Table 1 Dietary and metabolic data (median and range) in control group and patients with partial (PG) or total gastrectomy (TG) (137; 76-292 pg/ml) and TG groups (165; 145-368 pg/ml), and was significantly greater (Po0.01) than the peak concentration in controls (83; 81-89 pg/ml) at 120 min.
Hormones concentrations and appetite ratings profiles
There were no significant differences between male and female participants for appetite ratings throughout the study, and no effects of age, study group, ghrelin or PYY 3À36 on these values.
Hunger and prospective consumption ratings were not different among the groups in all time points throughout the study. After meal ingestion, hunger and prospective consumption recoveries occurred at 180 min in controls (Po0.01 compared with t ¼ 1), at 120 min (Po0.01 compared with t ¼ 1) in the PG group, and at 150 min (Po0.01 compared with t ¼ 1) in the TG group. The peak of both hunger and prospective consumption occurred significantly earlier in the PG and the TG group compared with controls (Table 2) . Although baseline fullness ratings were significantly lower in the TG group (Table 2) , no difference in fasting PYY 3À36 concentrations was observed among the groups (Table 1) . Differently from controls, fullness increased significantly immediately after meal ingestion and was apparently more transient in the PG and TG groups (Table 2) .
There was no effect of ghrelin or PYY 3À36 concentrations on hunger, prospective consumption or fullness ratings (linear mixed effect regression model). Despite ghrelin concentrations across the study and postprandial ghrelin response were different among the groups, neither mean hunger ratings in each time point nor hunger profile across the study seemed to differ among the groups (Figure 2) .
Immediately after meal ingestion, a steep rise in fullness ratings was observed in both PG and TG groups; however, their PYY 3À36 concentrations were not different at this time point compared with baseline ( Figure 3 ). In the TG group, the peak of PYY 3À36 occurred at 30 min, and at this moment, PYY 3À36 concentrations was significantly higher than the immediate post-meal time point.
Discussion
Our results showed that fasting plasma ghrelin concentrations were significantly lower in the TG group compared with healthy subjects. This is in agreement with earlier reports (Jeon et al., 2004; Takachi et al., 2006) , and consistent with the established notion that the stomach is the main site for ghrelin production (Ariyasu et al., 2001; Hosoda et al., 2006) . It is of note, however, that plasma ghrelin concentration in TG patients is far from negligible, indicating substantial activity of ghrelin sources other than the stomach after TG. As the proximal stomach mucosa is largely preserved after gastric partial procedures, it is not surprising that fasting plasma ghrelin levels in PG group were at most slightly different from those of controls. Although our PG group comprised patients with different transit reconstructions, all patients had the antropyloric region plus part of the proximal stomach removed and the vagi nerves sectioned. Interestingly, it has been recently shown (Hosoda and Kangawa, 2008 ) that stomach ghrelin mRNA production is upregulated by vagotomy in both fed and fasted rats, suggesting an additional mechanism for residual ghrelin secretion in PG.
In healthy volunteers, plasma ghrelin concentrations decreased significantly after the test meal as reported earlier by others (Cummings et al., 2001) ; contrariwise, in both TG and PG patients plasma ghrelin concentrations were not affected by meal ingestion. The precise mechanisms that cause meal-related changes of plasma ghrelin levels have not been elucidated (Hosoda and Kangawa, 2008) . Also, it has been suggested that ghrelin secretion is under cephalic Ghrelin, PYY and energy balance in gastrectomy MM Kamiji et al control (Natalucci et al., 2005) , which may involve both vagal and sympathetic pathways (Hosoda and Kangawa, 2008) . Our study shows, for the first time, that although basal plasma ghrelin concentration was similar in PG and control groups, ghrelin response to a meal was abolished in the former. The lack of ghrelin response to a meal after Table 2 Hunger, prospective consumption and fullness ratings at baseline (t0), immediately after meal ingestion (t1) and postprandial nadir (time and value) and peak (time and value) in control group and patients with partial (PG) or total gastrectomy (TG)
Hunger Baseline ( and subjects with total gastrectomy (n ¼ 7) across the testing period.
gastrectomy, therefore, is likely to be related to vagotomy, rather than to the extension of gastrectomy. Gastric cancer patients after TG present significant body weight loss along with decreased plasma ghrelin, which raised the question whether the reduction in ghrelin secretion could be accounted for the body weight loss and appetite suppression after TG (Takachi et al., 2006) . It is noteworthy that fasting total ghrelin correlated negatively with REE in TG patients, which is of particular importance if we consider that the measured REE tended to be higher than the predicted REE in these patients. We speculate that, in this group, the increased REE could be resultant from a constantly low plasma ghrelin concentration.
We found no relationship between ghrelin and appetite variations, or between basal ghrelin and daily energy intake; in fact, we did observe higher energy intake in TG compared with other groups. This observation is in line with studies on gene knockout animal models (De Smet et al., 2006; Pfluger et al., 2008) , showing that endogenous ghrelin is not an essential regulator of food intake, but has a crucial function in the maintenance of energy balance. In addition, others (Natalucci et al., 2005; Di Francesco et al., 2006; Frecka and Mattes, 2008) have reported that ghrelin secretion is related to habitual eating patterns rather than to feeding elicitation. Besides, it is well established that an array of other mechanisms, including orosensory factors (Lavin et al., 2002) , and rises of hormones such as insulin, CCK, PYY and GLP-1 are involved in eliciting satiety in humans (Wren and Bloom, 2007) . Taken together, our results support the hypothesis that the constant and markedly lower ghrelin levels in TG patients may contribute to prevent their body weight gain by a mechanism other than food intake control. Also, ghrelin secreted by sources other than stomach (Hosoda et al., 2006; Wang et al., 2008) may have a function in the long-term regulation of body weight in TG.
We found a significant increase in PYY 3À36 levels at 30 min after meal in both PG and TG groups. Some authors (Abbott et al., 2005; Le Roux et al., 2005) have reported that an early postprandial PYY 3À36 increase may not be caused exclusively by direct contact of intraluminal contents with endocrine L cells in the distal bowel. Nevertheless, because gastrointestinal transit is exceedingly rapid in both PG and TG groups (Kamiji et al., 2009) , we suggest that, in gastrectomy, a direct stimulation of L cells by gut contents is responsible for the hormone response. Also, fullness ratings rose immediately after meal in both groups, and such increase occurred before the postprandial PYY 3À36 rise, suggesting that this hormone is not directly involved in early fullness in these patients.
Although individual small postprandial rises in plasma PYY were often observed in our healthy volunteers, they occurred at variable times after the test meal, resulting in a blunted average response. The small sample size may have contributed to the apparent lack of response. It is of note that negligible postprandial PYY responses to a mixed meal were also reported in other studies (Chan et al., 2006; Lomenick et al., 2009) .
Our study has some limitations. The small groups of subjects did not allow a subdivision of PG group accordingly to different reconstructions procedures. Also, the assessment of body composition in the subjects would enable a better interpretation of the REE values. As we did not measure Figure 3 PYY 3À36 concentrations and fullness ratings profiles (mean and s.e.m.) in controls (n ¼ 10), subjects with partial gastrectomy (n ¼ 14) and subjects with total gastrectomy (n ¼ 7) across the testing period.
octanoyl or des-octanoyl ghrelin, we do not know whether the ratio between these circulating ghrelin forms was distinct among the groups.
In summary, we showed that periprandial changes in plasma ghrelin are absent in subjects with TG or PG and vagotomy, and PYY 3À36 postprandial response to food intake is increased and early in these patients. Neither ghrelin nor PYY 3À36 plasma concentration related with appetite scores or energy intake in gastrectomy, showing that appetite control is likely to be independent of integrity of either stomach or afferent vagal fibers. Also, ghrelin correlates with REE in TG, indicating that ghrelin secreted by sources other than the stomach have a function in the long-term regulation of body weight in these subjects.
